Clinical Trials

30 enrolled

Biliary Tract Neoplasms

NCT03924466 2024-02-16

VUBAR

BreastGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

55 enrolled

Biliary Tract Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Transitional Cell, Pancreatic Neoplasms, Prostatic Neoplasms, Salivary Gland Neoplasms, Stomach Neoplasms, Uterine Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms, Cholangiocarcinoma

NCT06255262 2024-02-13

Durvalumab Combined With Surufatinib as Maintenance Therapy in Patients With Advanced Biliary Tract Cancer

30 enrolled

Biliary Tract Neoplasms

NCT06074029 2024-02-08

Exploratory Study on the Therapeutic Effect Prediction Model of Advanced BTC Immunotherapy

50 enrolled

Biliary Tract Neoplasms

NCT05520801 2023-12-19

CCGLC-002

2,000 enrolled

Biliary Tract Neoplasms, Carcinoma, Hepatocellular

NCT05935579 2023-11-15

Durvalumab and Lenvatinib With or Without Chemotherapy in First-Line Treatment of Advanced Biliary Tract Cancer

40 enrolled

Biliary Tract Neoplasms

NCT05156788 2023-08-15

Tislelizumab（Anti PD-1), Lenvatinib and GEMOX Transformation in the Treatment of Potentially Resectable, Locally Advanced Biliary Tract Cancer

40 enrolled

Biliary Tract Neoplasms

NCT04445532 2023-07-07

Hepatobiliary Tumors Tissue Samples Acquisition

GastrointestinalOther neoplasm

450 enrolled

Biliary Tract Neoplasms, Gallbladder Neoplasms, Carcinoma, Hepatocellular, Liver Neoplasms, Precancerous Conditions, Cholangiocarcinoma

NCT05743959 2023-05-22

ctDNA Detection of MRD in Predicting Postoperative Recurrence in Biliary Tract Cancers：A Multicenter Prospective Trial

100 enrolled

Biliary Tract Neoplasms, Cholangiocarcinoma, Neoplasm, Residual

NCT04010071 2023-03-29

Axitinib Plus Toripalimab as Second-line Treatment in Hepatobiliary Malignant Tumors

60 enrolled

Biliary Tract Neoplasms, Liver Neoplasms

NCT05723705 2023-03-27

LIVEROBOT

3,600 enrolled

Biliary Tract Diseases, Biliary Tract Neoplasms, Liver Diseases, Liver Neoplasms

NCT03475953 2023-03-03

REGOMUNE

BreastEndocrineGastrointestinalGenitourinaryHead & NeckNETOther solid neoplasmSarcomaThoracic

747 enrolled

Gastro-enteropancreatic neuroendocrine tumor, Turcot syndrome, Tertiary Lymphoid Structures, Mesothelioma, Malignant, Biliary Tract Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Carcinoma, Hepatocellular, Neoplasm Metastasis, Sarcoma, Stomach Neoplasms, Thyroid Neoplasms, Triple Negative Breast Neoplasms

NCT05742750 2023-02-24

A Phase Ib/II Clinical Study of Camrelizumab and Apatinib Plus GP in the Treatment of Advanced Biliary Tract Cancer

48 enrolled

Biliary Tract Neoplasms

NCT05237193 2023-01-17

A Prospective Study of UCAD for Diagnosing Benign or Malignant Biliary Obstruction and Follow-up

400 enrolled

Biliary Tract Neoplasms, Disease, Gallbladder Neoplasms, Pancreatic Neoplasms

NCT05667350 2022-12-30

AssesSment of Early-deteCtion basEd oN liquiD Biopsy in Biliary Tract Cancer (ASCEND-BTC)

492 enrolled

Biliary Tract Neoplasms

NCT05509478 2022-09-10

LEADER-001

46 enrolled

Biliary Tract Neoplasms

NCT04856761 2022-08-18

A Study of Capecitabine Versus S-1 as Adjuvant Therapy in Patients With Biliary Tract Carcinoma After Surgical Resection

160 enrolled

Biliary Tract Neoplasms, Gallbladder Neoplasms, Recurrence, Cholangiocarcinoma

NCT05487443 2022-08-04

The Efficacy of Chemotherapy Combined With Immunocheckpoint Inhibitors in Advanced Biliary Malignancies

Phase 2/3 Unknown

50 enrolled

Biliary Tract Neoplasms

NCT04637048 2022-06-16

Observational Study on Patients With Hepatobiliary Tumors

1,000 enrolled

Biliary Tract Neoplasms, Gallbladder Neoplasms, Carcinoma, Hepatocellular, Stomach Neoplasms, Colorectal Neoplasms, Cholangiocarcinoma

NCT03110484 2022-06-15

Pemetrexed in Combination With Erlotinib as a Salvage Treatment in Patients With Metastatic Biliary Tract Cancer (BTC) Who Failed Gemcitabine Containing Chemotherapy: A Phase II Single Arm Prospective Study

44 enrolled

Biliary Tract Neoplasms

NCT04401709 2022-06-15

Gemcitabine+ Capecitabine Vs Capecitabine in Curatively Resected Biliary Tract Cancer

Phase 3 Unknown

490 enrolled

Biliary Tract Neoplasms

NCT05417230 2022-06-14

RC48-ADC Combinatioed Envolizumab in Locally Advanced or Metastatic Biliary Tract Cancer With Positive HER-2

29 enrolled

Biliary Tract Neoplasms

NCT03898895 2022-06-02

CORRECT

36 enrolled

Biliary Tract Neoplasms

NCT05320497 2022-04-15

Transparent Cap-assisted SpyGlass for Biliary Stricture

Phase NA Unknown

10 enrolled

Biliary Tract Neoplasms, Gallbladder Diseases

NCT05327582 2022-04-14

An Open-label, Phase I/II Study of PLENA Regimen in Patients With Unresectable Pancreatic Cancer or BTC

65 enrolled

Biliary Tract Neoplasms, Pancreatic Neoplasms

NCT05056116 2021-12-27

A Safety and Efficacy Study of Surufatinib Combination With Toripalimab in Patients With Recurrent Biliary Tract Cancer

Phase NA Unknown

30 enrolled

Biliary Tract Neoplasms

NCT04907864 2021-06-01

MIRACLE

112 enrolled

GastrointestinalThoracic

Biliary Tract Neoplasms, Cachexia, Lung Neoplasms, Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

NCT04584996 2021-03-08

CIRCUS

186 enrolled

Biliary Tract Neoplasms, Pancreatic Neoplasms

NCT04731220 2021-01-29

A Questionnaire Survey for Biliary Tract Cancers

12,000 enrolled

Biliary Tract Neoplasms

NCT04692051 2020-12-31

A Phase II Study for Nab-paclitaxel Plus Cisplatin vs Gemcitabine Plus Cispatin as First Line Chemotherapy in Advanced Biliary Tract Cancer

100 enrolled

Biliary Tract Neoplasms

NCT04333927 2020-06-23

ACCORD

92 enrolled

Biliary Tract Neoplasms, Gallbladder Neoplasms, Cholangiocarcinoma

NCT04300959 2020-03-09

Anlotinib in Combination With PD1 With Gemcitabine Plus(+)Cisplatin for Unresectable or Metastatic Biliary Tract Cancer

80 enrolled

Biliary Tract Neoplasms

NCT03139487 2020-01-06

PRIORITY